Director, New Product Planning

Director, New Product Planning

Candidates should be located in Denver, Bay Area, Los Angeles (SoCal), or Seattle.

Job Description

We are a fast-growing and dynamic organization seeking a Director, New Product Planning to join our team. This role is a commercial leader responsible for shaping the direction and commercialization of the company’s pipeline and future growth portfolio. Serving as a critical bridge between the marketplace and enterprise leadership, this role drives customer-centric strategy through deep engagement with healthcare stakeholders, key opinion leaders (KOLs), health systems, payers, patients, and industry influencers.

The Director leads the generation and integration of market insights that inform portfolio prioritization, clinical development strategy, business development decisions, and commercialization planning. This position influences key investment decisions and ensures that customer, market, and competitive perspectives are embedded throughout the product lifecycle.

Working across Commercial, Medical Affairs, Clinical Development, Market Access, Regulatory and Business Development, the Director provides leadership for pipeline assets from early development through launch readiness while helping shape the organization’s long-term growth strategy.

Good things are happening at Omeros!

Who is Omeros?

Omeros is an innovative biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for both large-market and orphan indications, with a focus on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead complement inhibitor YARTEMLEA® (narsoplimab-wuug), which targets the lectin pathway’s effector enzyme MASP-2, is FDA-approved and commercially available in the U.S. for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients aged two years and older. OMS1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials.

Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS906), an inhibitor of MASP-3, the alternative pathway’s key activator, which is in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder, which is fully funded by the National Institute on Drug Abuse, and a growing portfolio of novel recombinant antibodies targeting multidrug-resistant organisms and novel molecular and cellular therapeutic programs for oncology. For more information about Omeros and its programs, visit www.omeros.com.

What are your job responsibilities?

Enterprise Market and Customer Strategy

• Serves as the voice of the customer and marketplace across pipeline and portfolio planning activities
• Leads engagement with healthcare providers, KOLs, payer organizations, integrated delivery networks, and health system executives to identify emerging trends, unmet needs, and market opportunities
• Establishes and oversee comprehensive insight-generation strategies that influence development, commercialization, and lifecycle management decisions
• Synthesizes complex market intelligence into actionable recommendations for commercial and executive leadership
• Builds and maintains a network of influential external stakeholders to inform strategic decision-making and strengthen organizational credibility

Portfolio and New Product Planning Leadership

• Leads commercial assessments and evaluations for pipeline assets, lifecycle opportunities, and business development initiatives
• Directs the development of target product profiles, value propositions, commercialization strategies, and portfolio recommendations
• Drives planning assets by assessing market attractiveness, competitive differentiation, patient impact, and long-term business value
• Partners with Business Development to assess external innovation opportunities and acquisition targets
• Influences clinical development strategies by ensuring customer and market perspectives are incorporated into study design, endpoint selection, evidence generation, and development planning

Competitive Intelligence and Commercialization Strategy

• Establishes and oversees competitiv…